Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2023

Open Access 01-12-2023 | Cystectomy | Case report

Bladder carcinosarcoma treated by cystectomy and adjuvant chemotherapy with good outcomes: a case report

Authors: Fadila Kouhen, Zineb Dahbi, Mohammed Afif, Meriem Chihabeddine, Nadia Errafiy, Kenza Oqbani, Youssef Omor, Amal Elhossini

Published in: Journal of Medical Case Reports | Issue 1/2023

Login to get access

Abstract

Background

Primary carcinosarcoma of the bladder is a rare and highly aggressive tumor, representing less than 1% of all bladder neoplasms. There is no specific treatment guideline has for carcinosarcoma of the bladder, and majority of published patients was treated exclusively by surgery.

Case presentation

We report a case of 65-year-old Moroccan man, presented with macroscopic hematuria, pollakiuria and painful urination. Histological analysis showed a biphasic epithelial and mesenchymal proliferation, with invasion of lamina propria and muscularis, compatible with diagnosis of bladder carcinosarcoma. The patient was treated with cystectomy and adjuvant chemotherapy based on gemcitabin-cisplatin, 18 months after treatment, patient still free of recurrence.

Conclusion

Carcinosarcoma of the urinary bladder is a rare and aggressive tumor regardless treatment. A multidisciplinary management based on radical cystectomy and combined adjuvant treatments can improve prognosis. In this work, we suggest to propose adjuvant chemotherapy whenever possible.
Literature
1.
go back to reference Wright JL, Black PC, Brown GA, et al. Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder. J Urol. 2007;178:2302–6.CrossRefPubMed Wright JL, Black PC, Brown GA, et al. Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder. J Urol. 2007;178:2302–6.CrossRefPubMed
2.
3.
go back to reference Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D; CARE Group. The CARE guidelines: consensus-based clinical case reporting guideline development. J Med Case Rep. 2013;7:223. Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D; CARE Group. The CARE guidelines: consensus-based clinical case reporting guideline development. J Med Case Rep. 2013;7:223.
6.
go back to reference Malla M, Wong FW, Trapeta R, et al. Sarcomatoid carcinoma of the urinary bladder. Clin Genitourin Cancer. 2016;14(5):366–72.CrossRefPubMed Malla M, Wong FW, Trapeta R, et al. Sarcomatoid carcinoma of the urinary bladder. Clin Genitourin Cancer. 2016;14(5):366–72.CrossRefPubMed
7.
go back to reference Basibuyuk I, Topaktaş R, Elbir F. Bladder carcinosarcoma: a case report with review of the literature. Arch Ital Urol Androl. 2017;89(3):240–2.CrossRefPubMed Basibuyuk I, Topaktaş R, Elbir F. Bladder carcinosarcoma: a case report with review of the literature. Arch Ital Urol Androl. 2017;89(3):240–2.CrossRefPubMed
9.
go back to reference Baseskioglu B, Duman BB, Kara IO, et al. Early detection and gemcitabine/cisplatin combination positively affect survival in sarcomatoid carcinoma of the urinary bladder. Asian Pac J Cancer Prev. 2012;13:5729–33.CrossRefPubMed Baseskioglu B, Duman BB, Kara IO, et al. Early detection and gemcitabine/cisplatin combination positively affect survival in sarcomatoid carcinoma of the urinary bladder. Asian Pac J Cancer Prev. 2012;13:5729–33.CrossRefPubMed
Metadata
Title
Bladder carcinosarcoma treated by cystectomy and adjuvant chemotherapy with good outcomes: a case report
Authors
Fadila Kouhen
Zineb Dahbi
Mohammed Afif
Meriem Chihabeddine
Nadia Errafiy
Kenza Oqbani
Youssef Omor
Amal Elhossini
Publication date
01-12-2023
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2023
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-023-04028-3

Other articles of this Issue 1/2023

Journal of Medical Case Reports 1/2023 Go to the issue